PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-07

Date Title Company
07-Feb-2023 Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease Businesswire
07-Feb-2023 Have model organisms evolved too far? University of Birmingham
07-Feb-2023 Catalent, Inc. Reports Second Quarter Fiscal 2023 Results Businesswire
07-Feb-2023 Freudenberg Medical Expands Medical Tubing Production to Massachusetts Businesswire
07-Feb-2023 KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session Businesswire
07-Feb-2023 Aplantex Announces the Composition of Its C-Suite Businesswire
07-Feb-2023 British biotech firm secures coveted FDA designation in bid to develop world’s first treatment for rare, incurable and deadly disease SynaptixBio
07-Feb-2023 iTeos to Present at SVB Securities Global Biopharma Conference iTeos Therapeutics
07-Feb-2023 AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 AC Immune
07-Feb-2023 Pharmaceutical Serialisation – What’s Coming Down the Line? Domino Printing Sciences
07-Feb-2023 Biosynth’s Peptide Division successfully completed GMP inspection in Lelystad Biosynth
07-Feb-2023 Nearly Half of Global Consumers Frustrated by the English Language Dominance of the Internet and Technology Businesswire
07-Feb-2023 TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials Businesswire
07-Feb-2023 New Country Managing Director and Head of Human Pharma appointed for Boehringer Ingelheim UK & Ireland Boehringer Ingelheim UK & Ireland
07-Feb-2023 ABB’s latest distributed control system release helps accelerate digital transformation in process automation ABB
07-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Feb-2023 Coulter Partners places three Board Directors at Our Future Health Trading Ltd Coulter Partners
07-Feb-2023 Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner Oxford Science Enterprises
07-Feb-2023 TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials TILT Biotherapeutics
07-Feb-2023 Five free ways to help your child or teenager with their mental health Wysa